⌘K
t
On 14 March 2024, HeiQ PLC completed a fundraising by issuing 28,000,000 New Ordinary Shares. On the same date, directors Carlo Centonze (via Cortegrande AG), Esther Dale-Kolb, and Xaver Hangartner acquired ordinary shares at 8.7 pence each following the conversion of convertible loan notes; Cortegrande AG acquired 9,699,193 shares and sold 890,400 shares, resulting in Carlo Centonze holding 14.21% of the ordinary shares. HeiQ PLC also extended its accounting reference date to 30 June and expects to publish unaudited interim financial statements for the 12-month period ending 31 December 2023 by 31 March 2024.
| Date | 14 Mar 2024 |
| Time | 13:23:16 |
| Category | Director/PDMR dealings |
| ID | 9172G |
14 March 2024
HeiQ PLC
("HeiQ" or "the Company")
Completion of Fundraising, PDMR Dealings & Audit Update
The Company announces the completion of the Fundraising following the issuance of the 28,000,000 New Ordinary Shares and Admission this morning.
Accordingly, the Company announces the following dealings by certain Directors & their persons closely associated, following the automatic conversion of the Convertible Loan Notes and the issuance of the Convertible Loan Note Shares to them, as set out below.
|
Name |
Number of Existing Ordinary Shares |
Number of Convertible Loan Notes Shares acquired (2) (3) |
Number of Ordinary Shares held following Admission |
Percentage of the Ordinary Shares held following Admission |
|
Carlo Centonze (1) |
15,142,533 |
8,808,793 |
23,951,326 |
14.21 |
|
Esther Dale-Kolb |
902,986 |
180,974 |
1,083,960 |
0.64 |
|
Xaver Hangartner |
493,746 |
73,368 |
567,114 |
0.34 |
(1) Includes shares held by close relatives and controlled entities.
(2) Acquired by Cortegrande AG, a company wholly owned by Carlo Centonze.
(3) Of the total 9,699,193 Convertible Loan Notes Shares acquired by Cortegrande AG, 890,400 were sold to an existing shareholder at the Issue Price to satisfy demand.
Audit update
As previously announced, the Company has deemed it prudent to extend its accounting reference date to 30 June to enable the incoming auditor to properly onboard and complete the audit in a reasonable timeframe. The Company is preparing unaudited interim financial statements for the 12-month period ending 31 December 2023, which it expects to publish by 31 March 2024. The Company's next set of audited financial reports and accounts will be for the period 1 January 2023 to 30 June 2024 and will be published by 31 October 2024. The Company continues to seek a replacement auditor and will provide a further update in due course.
Unless otherwise defined, capitalised terms shall have the same meaning as those set out in its announcement regarding the Fundraising dated 15 February 2024.
The notification below, is made in accordance with the requirements of the UK Market Abuse Regulation.
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||||||||
|
a)
|
Name
|
Cortegrande AG |
|||||||||
|
2
|
Reason for the notification |
||||||||||
|
a)
|
Position/status
|
Person closely associated with Carlo Centonze, Chief Executive Officer of HeiQ Plc |
|||||||||
|
b)
|
Initial notification /Amendment |
Initial Notification |
|||||||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||
|
a)
|
Name
|
HeiQ plc |
|||||||||
|
b)
|
LEI |
213800IGT65IMJDO4S03
|
|||||||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||||||||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares of 5 pence each
ISIN: GB00BN2CJ299
|
|||||||||
|
b)
|
Nature of the transaction |
1) Acquisition of new ordinary shares following conversion of convertible loan notes
2) Sale of ordinary shares
|
|||||||||
|
c)
|
Price(s) and volume(s)
|
|
|||||||||
|
d)
|
Aggregated information
- Aggregated volume - Price |
N/A
|
|||||||||
|
e)
|
Date of the transaction |
14 March 2024
|
|||||||||
|
f)
|
Place of the transaction
|
Outside a trading venue |
|||||||||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
|
a)
|
Name
|
Esther Dale-Kolb |
||||
|
2
|
Reason for the notification |
|||||
|
a)
|
Position/status
|
Non-Executive Chair |
||||
|
b)
|
Initial notification /Amendment |
Initial Notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a)
|
Name
|
HeiQ plc |
||||
|
b)
|
LEI |
213800IGT65IMJDO4S03
|
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares of 5 pence each
ISIN: GB00BN2CJ299
|
||||
|
b)
|
Nature of the transaction |
Acquisition of new ordinary shares following conversion of convertible loan notes |
||||
|
c)
|
Price(s) and volume(s)
|
|
||||
|
d)
|
Aggregated information
- Aggregated volume - Price |
N/A
|
||||
|
e)
|
Date of the transaction |
14 March 2024
|
||||
|
f)
|
Place of the transaction
|
Outside a trading venue |
||||
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
|
a)
|
Name
|
Xaver Hangartner |
||||
|
2
|
Reason for the notification |
|||||
|
a)
|
Position/status
|
Chief Financial Officer |
||||
|
b)
|
Initial notification /Amendment |
Initial Notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a)
|
Name
|
HeiQ plc |
||||
|
b)
|
LEI |
213800IGT65IMJDO4S03
|
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares of 5 pence each
ISIN: GB00BN2CJ299
|
||||
|
b)
|
Nature of the transaction |
Acquisition of new ordinary shares following conversion of convertible loan notes |
||||
|
c)
|
Price(s) and volume(s)
|
|
||||
|
d)
|
Aggregated information
- Aggregated volume - Price |
N/A
|
||||
|
e)
|
Date of the transaction |
14 March 2024
|
||||
|
f)
|
Place of the transaction
|
Outside a trading venue |
||||
For further information, please contact:
|
HeiQ Plc Carlo Centonze (CEO) |
+41 56 250 68 50 |
|
Cavendish Capital Markets Limited (Broker) Stephen Keys / Callum Davidson |
+44 (0) 207 397 8900 |
|
SEC Newgate (Media Enquiries) Elisabeth Cowell / Molly Gretton / Tom Carnegie |
+44 (0) 20 3757 6882 |
Further information on the Company can be found on its website at: https://www.heiq.com/investor-relations/
This announcement should be read in its entirety. In particular, the information in the "Important Notices" section of the announcement should be read and understood.
About HeiQ
HeiQ is a Swiss-based international company that innovates pioneering and differentiating materials in partnership with established global brands. We bridge the academic and commercial worlds to conceive performance-enhancing materials and technologies, working with aligned brands to research, manufacture and bring products to market, aiming for lab to consumer in months. Our goal is to improve the lives of billions by innovating the materials that go into everyday products, making them more hygienic, comfortable, protective, and sustainable.
Our strong IP portfolio positions us as an innovation leader for niche, premium and high-margin products in the textile chemicals, man-made fibers, paints and coatings, antimicrobial plastics, probiotics and household cleaner markets. We have also expanded into healthcare facilities, probiotic cleaning, and hygiene coatings markets to help make hospitals and healthcare environments more hygienic.
We have developed over 200 technologies in partnership with 300 major brands. With a substantial research and development pipeline, including key technology development projects HeiQ AeoniQ, HeiQ ECOS, HeiQ GrapheneX, and HeiQ Synbio, HeiQ aims to deliver shareholder value through sales growth and entry into new lucrative markets through disruptive innovation and M&A.
We have built a strong reputation for ESG & sustainable innovation, having won multiple awards including the Swiss Technology Award twice and the Swiss Environmental Award. Under experienced leadership, we are committed to driving our profit in close connection with people and the planet. For more information, please visit www.heiq.com.